-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637.O3.6 637. Myelodysplastic Syndromes – Clinical and Epidemiological III

Symposia: Myelodysplastic Syndromes – Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, MDS, adult, Translational Research, epidemiology, elderly, Clinical Research, genomics, Chronic Myeloid Malignancies, Diseases, real-world evidence, registries, Biological Processes, Myeloid Malignancies, survivorship, Technology and Procedures, Study Population, Human, molecular testing
Sunday, December 11, 2022: 9:30 AM-11:00 AM
252-254 (Ernest N. Morial Convention Center)
Moderators:
Maximilian F. Stahl, MD, Dana Farber Institute and Andrew Hantel, MD, Dana-Farber Cancer Institute
Disclosures:
No relevant conflicts of interest to declare.
Updates in prognostication and classification of MDS
9:30 AM

Somedeb Ball, MD1, Avani M Singh, MD2, Najla Al Ali, MD3*, Luis E. E. Aguirre, MD4, Akriti G Jain, MD4, Zaker I. Schwabkey, MD5, Sara M Tinsley-Vance, PhD, ANP1, Onyee Chan, MD1*, Andrew Kuykendall, MD6, Kendra Sweet, MD7, Jeffrey E. Lancet, MD8, Eric Padron, MD9, David A. Sallman, MD3 and Rami S. Komrokji9

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Division of Hematology and Oncology, USF / Moffitt Cancer Center & Research Institute, Tampa, FL
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Division of Hematology and Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Division of Hematology and Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Department of Malignant Hematology, H. Lee Mofitt Cancer Center, Tampa, FL
7Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL
8Department of Malignant Hematology, H. Lee Moffitt Cancer Ctr. %26 Rsrch. Institute, Tampa, FL
9Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

9:45 AM

Elisabetta Sauta, PhD1*, Marie Robin, MD, PhD2, Matteo Bersanelli, PhD3*, Erica Travaglino, BsC4*, Manja Meggendorfer, PhD5, Lin-Pierre Zhao, MD2*, Juan Carlos Caballero Berrocal, MD6*, Giulia Maggioni, MD7*, Cristina Astrid Tentori, MD7*, Massimo Bernardi, MD8*, Carmen Di Grazia, MD9*, Luca Vago, MD, PhD8, Giulia Rivoli, MD10*, Lorenza Borin, MD11*, Saverio D'Amico, MSc1*, Marta Ubezio, MD7*, Alessia Campagna7*, Antonio Russo, MD7*, Daniele Mannina, MD7*, Luca Lanino12*, Patrizia Chiusolo, MD13*, Luisa Giaccone, MD, PhD14*, Maria Teresa Voso, MD15, Marta Riva, MD16*, Esther Natalie Oliva, MD17, Matteo Zampini, PhD7*, Elena Riva7*, Olivier Nibourel, PhD18*, Claudia Sala, PhD19*, Marilena Bicchieri, PhD3*, Niccolo Bolli, MD20*, Alessandro Rambaldi, MD21, Francesco Passamonti, MD22*, Victor Savevski, MEng1*, Armando Santoro, MD23*, Ulrich Germing24*, Shahram Kordasti, MD, PhD25, Valeria Santini, MD26, Maria Diez-Campelo, MD6,27*, Guillermo Sanz, MD, PhD28, Francesc Solé, PhD29, Wolfgang Kern, MD30, Uwe Platzbecker, MD31, Lionel Ades2, Pierre Fenaux32, Torsten Haferlach, MD30, Castellani Gastone, PhD19* and Matteo G. Della Porta, MD33*

1Artificial Intelligence Center, Humanitas Research Hospital, Rozzano (Milan), Italy
2Department of Hematology and Bone Marrow Transplantation, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
3IRCCS Humanitas Research Hospital, Rozzano, Italy
4Cancer Center, IRCCS Humanitas Research Hospital, Rozzano - Milan, Italy
5MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany
6Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain
7Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy
8Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy
9Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy
10Ospedale Policlinico San Martino, UO Ematologia e Terapie Cellulari, Genova, Italy
11Ospedale San Gerardo, Monza, Italy
12Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy
13Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
14Department of Oncology and Hematology, SSD Stem Cell Transplant Center, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
15Policlinico Tor Vergata & Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
16Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, MI, Italy
17Division of Hematology, Azienda Ospedaliena (B-M-M), Reggio Calabria, Italy
18CHRU Lille, Lille, France
19University of Bologna & National Institute of Nuclear Physics (INFN), Bologna, Italy
20Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico & University of Milan, Milan, Italy
21Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
22Division of Hematology, University Hospital Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi, University of Insubria, Varese, Italy
23Humanitas University and IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy
24Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany
25Systems Cancer Immunology, Comprehensive Cancer Centre, King's College London, London, United Kingdom
26AOU Careggi-University of Florence, Florence, Italy
27Institute of Biomedical Research of Salamanca, Hospital Universitario de Salamanca, Salamanca, Spain
28Hematology Deparment, Health Research Institute La Fe, Valencia, Spain
29Institut De Recerca Josep Carreras, Badalona, ESP
30MLL Munich Leukemia Laboratory, Munich, Germany
31Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
32Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
33Cancer Center, Humanitas Research Hospital and Center for Accelerating Leukemia Research (CALR), Humanitas University, Artificial Intelligence Center, Milan, Italy

10:00 AM

Luis E. E. Aguirre, MD1, Najla Al Ali, MS2, Somedeb Ball, MD1, Avani M Singh, MD1, Akriti G Jain, MD3, Onyee Chan, MD1*, Zaker I. Schwabkey, MD1, Sara M Tinsley-Vance, PhD, ANP1, Andrew Kuykendall, MD1, Kendra Sweet, MD1, Jeffrey E. Lancet, MD1, Eric Padron, MD1, David A. Sallman, MD2 and Rami S. Komrokji, MD1

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, WESLEY CHAPEL, FL

10:15 AM

Constance Baer, PhD1, Sandra Huber, PhD1*, Stephan Hutter, PhD1*, Manja Meggendorfer, PhD1, Niroshan Nadarajah1*, Wencke Walter, PhD1*, Uwe Platzbecker, MD2, Katharina Götze3*, Wolfgang Kern, MD1, Torsten Haferlach, MD1, Gregor Hoermann, MD, PhD1 and Claudia Haferlach, MD1

1MLL Munich Leukemia Laboratory, Munich, Germany
2Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
3Department of Internal Medicine III, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany

10:30 AM

Claudia Haferlach, MD, Sandra Huber, PhD*, Heiko Mueller, PhD*, Constance Baer, PhD, Gregor Hoermann, MD, PhD, Manja Meggendorfer, PhD, Stephan Hutter, PhD*, Wolfgang Kern, MD and Torsten Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

10:45 AM

Adrian Mosquera Orgueira1*, Manuel Perez Encinas, MD2*, Nicolas A Diaz Varela, MD3*, Elvira Mora4*, Marina Díaz-Beyá, MD, PhD5*, María Julia Montoro, MD, PhD6*, Helena Pomares, PhD7*, Fernando Ramos8*, Mar Tormo9, Andres Jerez10*, Josep F Nomdedeu, MD, PhD11*, Carlos De Miguel Sanchez12*, Arenillas Leonor, MD, PhD13*, Paula Cárcel, MD14*, Maria Teresa Cedena Romero, MD, PhD15*, Blanca Xicoy, MD16*, Eugenia Rivero, MD17*, Rafael Andres del Orbe Barreto18*, Maria Diez-Campelo, MD19,20*, Luis E. Benlloch21*, Davide Crucitti22* and David Valcárcel, MD, PhD23

1Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, SANTIAGO DE COMPOSTELA, Spain
2Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
3Hospital Central de Asturias, Oviedo, A Coruña, Galicia, ESP
4Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain
5Hospital Clinic, Dept. of Hematology, IDIBAPS, Barcelona, Spain, Barcelona, Spain
6Department of Hematology, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
7Hematology Department., Hospital Duran i Reynals. Institut Català d'Oncologia, Hospital Duran i Reynals. Institut Català d'Oncologia, Hospitalet, BARCELONA, Spain
8Department of Hematology, Hospital Universitario De LeóN and Instituto De Biomedicina (IBIOMED), Un, Leon, Spain
9Servicio de Hematología. Hospital Clínico Universitario de Valencia, Valencia, Spain
10Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, MURCIA, Spain
11Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
12Hospital Universitario de Álava - Sede Txagorritxu, Vitoria-Gasteiz, Spain
13Laboratoris de Citologia Hematològica i Citogenètica, servei de Patologia, Hospital del Mar. GRETNHE- Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain
14Department of Hematology, Hospital Público Universitario de la Ribera, Alzira, Valencia, Spain
15Hospital 12 de Octubre, Madrid, Spain
16HU German Trias i Pujol - Institut Català d' Oncologia, Barcelona, Spain
17Department of Hematology, University Hospital Arnau de Vilanova, Lleida, Spain
18Edif. Laboratorios, planta baja., Hospital Universitario Cruces Servicio de Hematología. Sección Eritropatología – Hem. Molecular, Barakaldo, Spain
19Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
20Institute of Biomedical Research of Salamanca, Hospital Universitario de Salamanca, Salamanca, Spain
21Grupo Español de Síndromes Mielodisplásicos (GESMD), Valencia, Spain
22Instituto de Investigacions Santiarias de Santiago de Compostela (IDIS-CHUS), Santiago de Compostela, Spain
23Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

*signifies non-member of ASH